ewsba.se
Latest World Business Technology Sports Health Culture Video
Checking…
All Yahoo Investing Bloomberg CNBC Nasdaq NYT LiveMint Dow Jones Sky News

Jefferies lowers Aevex stock price target on valuation reset

Investing.com · News 7m ago

Raymond James raises Lexeo Therapeutics price target on trial data

Investing.com 7m ago

Larimar Therapeutics director Joseph Truitt buys $9,791 in stock.

Investing.com 7m ago

Truist reiterates Aramark stock rating on solid quarter results

Investing.com 7m ago

J&J strikes $2.2 billion buyout deal for eye disease biotech Ollin Biosciences

Investing.com 9m ago

Business coverage

VEON targets 12-15% annual growth, $200M shareholder returns

Investing.com · News 11m ago

CG Oncology reports positive phase 3 trial results for bladder cancer

Investing.com · News 11m ago

Swarmer completes acquisition of Vataga Drone IP and team

Investing.com · News 11m ago

Creative Realities earnings missed by $0.25, revenue fell short of estimates

Investing.com · News 11m ago

Why is CG Oncology stock surging today?

Investing.com · News 14m ago

Our Bond approves conversion of Series B preferred stock to common shares

Investing.com · News 15m ago

Kodiak Sciences at Jefferies Global Healthcare Conference: pipeline nears key readouts

Investing.com · News 19m ago

Parabilis Medicines at Jefferies Global Healthcare Conference: pipeline gains

Investing.com · News 19m ago

Sebi panel to review IPO, FPO and QIP rules, rationalise disclosure norms

LiveMint · Markets 19m ago

NewGenIvf provides business update across multiple ventures

Investing.com · News 20m ago
We use analytics cookies to understand website usage.